Advertisement
Advertisement

A Leading Clinical Investigator Makes the Case for Pediatric Metabolic Risk Clustering


For decades, Sheela N. Magge, MD, MSCE, has conducted clinical, patient-orientated research that has led to field-changing studies in the understanding of cardiometabolic risk factors among youth and adolescents.

Sheela Magge, MD, MSCE
Sheela Magge, MD, MSCE

In her Nov. 17 ObesityWeek key lecture, Pediatric Obesity – the Effects of Body Composition, Ancestry, and Ectopic Fat on Cardiometabolic Risk, Dr. Magge will share insights into her research on the effects of body composition and other factors besides BMI on cardiometabolic risk.

“With the high prevalence of pediatric obesity in the U.S., one of the things I have often asked is: How do we identify which kids are of the highest cardiovascular and metabolic risks?  We have so many children referred for obesity, but not all are at equal risk for comorbidities and complications of their obesity. Identifying those at highest risk will help us effectively target the population with preventive measures,” said Dr. Magge, a professor of pediatrics and the chief of the Division of Pediatric Endocrinology & Diabetes at Johns Hopkins University School of Medicine.

Curiosity about this aspect of health led Dr. Magge to conduct studies focusing on the differential effect of body composition on cardiometabolic risk and why certain groups seem to be at higher risk for complications. A multi-year NIH-funded project examined youth populations of South Asian Americans, African Americans, and white Americans, measuring differences in visceral fat and other ectopic fat depots, as well as their relationships to metabolic outcomes such as insulin sensitivity and resistance.

Dr. Magge said that her research points to the heterogeneity of adipose tissue and of how it seems to structurally and functionally manifest differently across populations.

“All adipose is not the same. It depends on where it is stored. Is it visceral? Is it subcutaneous?” Dr. Magge said. “What we think is happening is that much of the pathology and complications of obesity might be associated with where the fat is stored. If you are not storing your fat in the right place, then it can become toxic for the body.”

Applying this insight to population differences, Dr. Magge was the senior author on a 2026 study demonstrating differences in insulin secretion and sensitivity among different U.S. ancestry groups.

“Both the African American and the South Asian populations had much more insulin resistance compared to white youth, but the South Asian group hyper-secreted insulin,” Dr. Magge said. “And what is also interesting is that the South Asians, compared to the African Americans, had much more visceral and liver fat even at a median age of 19–20 years.”

These differences manifested in other ways that were clinically measurable, such as through arterial stiffness studies with pulse velocity and pulse wave analysis.

n clinical practice, we need to consider metabolic risk clustering. There is no one definition for risk, there are clusters of risk factors. We must account for ancestry, background, cardiovascular disease risk, family history, and genetics.

— Sheela N. Magge, MD, MSCE

“We found that the South Asians had a higher augmentation index compared to their peers. These are relatively healthy individuals, but their hearts are already pushing out against a greater pressure at a relatively young age—and that’s kind of shocking,” Dr. Magge said. 

Dr. Magge and her colleagues are now working to continue this research as a longitudinal study to examine these differences and the mechanisms of response as the study groups become adults.

In her Key Lecture, Dr. Magge will touch upon what these and future findings might mean for research, clinical screening, and more personalized clinical care.

“More studies of pediatric populations are needed,” Dr. Magge said. “In clinical practice, we need to consider metabolic risk clustering. There is no one definition for risk, there are clusters of risk factors. We must account for ancestry, background, cardiovascular disease risk, family history, and genetics. It’s important that we individualize our practice for whom we are treating.”

Dr. Magge’s Key Lecture takes place Tuesday, Nov. 17, 10–11 am ET, at National Harbor 10-11, in the Gaylord National Resort & Convention Center.

Other ObesityWeek 2026 Key Lectures on Tuesday include (all times are listed in ET and all room locations are in the Gaylord National Resort & Convention Center):

Reserve Nov. 7–10, 2027, on your calendar for the live conference sessions of TOS 45th Annual Scientific Meeting
at ObesityWeek 2027.

More details will be posted as they become available.



Advertisement